Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-Prostatectomy

NCT02849990 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02849990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-Prostatectomy
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
March 9, 2017
Completion date
December 10, 2020
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii prostate adenocarcinoma ajcc v7, stage iii prostate cancer ajcc v7, stage iv prostate adenocarcinoma ajcc v7, stage iv prostate cancer ajcc v7